TY - JOUR AU - Nutting, C. PY - 2016 DA - 2016// TI - Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines JO - J Laryngol Otol VL - 130 UR - https://doi.org/10.1017/S0022215116000463 DO - 10.1017/S0022215116000463 ID - Nutting2016 ER - TY - JOUR AU - Posner, M. R. AU - Hershock, D. M. AU - Blajman, C. R. AU - Mickiewicz, E. AU - Winquist, E. AU - Gorbounova, V. PY - 2007 DA - 2007// TI - Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa070956 DO - 10.1056/NEJMoa070956 ID - Posner2007 ER - TY - JOUR AU - Nguyen-Tan, P. F. AU - Zhang, Q. AU - Ang, K. K. AU - Weber, R. S. AU - Rosenthal, D. I. AU - Soulieres, D. PY - 2014 DA - 2014// TI - Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long-term report of efficacy and toxicity JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.3925 DO - 10.1200/JCO.2014.55.3925 ID - Nguyen-Tan2014 ER - TY - JOUR AU - Trotti, A. AU - Bellm, L. A. AU - Epstein, J. B. AU - Frame, D. AU - Fuchs, H. J. AU - Gwede, C. K. PY - 2003 DA - 2003// TI - Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review JO - Radiother Oncol VL - 66 UR - https://doi.org/10.1016/S0167-8140(02)00404-8 DO - 10.1016/S0167-8140(02)00404-8 ID - Trotti2003 ER - TY - STD TI - Prescribing information: Mucosta® tablets 100mg, Ohtsuka Japan Inc, 2017 (In Japanese). Available from: https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/2329021. UR - https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/2329021 ID - ref5 ER - TY - JOUR AU - Matsuda, T. AU - Yamada, H. AU - Hoshi, K. AU - Ichikawa, Y. AU - Sakane, T. AU - Mizushima, Y. PY - 1994 DA - 1994// TI - The beneficial effect of rebamipide on recurrent oral aphthous ulcers in Behcet’s disease JO - J Clin Exp Med VL - 170 ID - Matsuda1994 ER - TY - JOUR AU - Matsuda, T. AU - Ohno, S. AU - Hirohata, S. AU - Miyanaga, Y. AU - Ujihara, H. AU - Inaba, G. PY - 2003 DA - 2003// TI - Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet’s disease: a randomized, double-blind, placebo-controlled study JO - Drugs R D VL - 4 UR - https://doi.org/10.2165/00126839-200304010-00002 DO - 10.2165/00126839-200304010-00002 ID - Matsuda2003 ER - TY - JOUR AU - Nabeta, I. AU - Nakamura, K. AU - Kimura, M. AU - Kaya, M. AU - Tsuneizumi, M. AU - Nakagami, K. PY - 2010 DA - 2010// TI - The effect of rebamipide fir prevention of mucositis associated with anthracycline chemotherapy for breast cancer JO - J Jpn Soc Hosp Pharm VL - 46 ID - Nabeta2010 ER - TY - JOUR AU - Yasuda, T. AU - Chiba, H. AU - Satomi, T. AU - Matsuo, A. AU - Kaneko, T. AU - Chikazu, D. PY - 2011 DA - 2011// TI - Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study JO - J Oral Maxillofac Res VL - 2 ID - Yasuda2011 ER - TY - JOUR AU - Yokota, T. AU - Ogawa, T. AU - Takahashi, S. AU - Okami, K. AU - Fujii, T. AU - Tanaka, K. PY - 2017 DA - 2017// TI - Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3295-4 DO - 10.1186/s12885-017-3295-4 ID - Yokota2017 ER - TY - JOUR AU - Chaitanya, B. AU - Pai, K. M. AU - Yathiraj, P. H. AU - Fernandes, D. AU - Chhaparwal, Y. PY - 2017 DA - 2017// TI - Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis JO - Oral Oncol VL - 72 UR - https://doi.org/10.1016/j.oraloncology.2017.07.024 DO - 10.1016/j.oraloncology.2017.07.024 ID - Chaitanya2017 ER - TY - JOUR AU - Worthington, H. V. AU - Clarkson, J. E. AU - Bryan, G. AU - Furness, S. AU - Glenny, A. -. M. AU - Littlewood, A. PY - 2011 DA - 2011// TI - Interventions for preventing oral mucositis for patients with cancer receiving treatment JO - Cochrane Database Syst Rev VL - 4 ID - Worthington2011 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gøtzsche, P. C. AU - Ioannidis, J. P. A. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000100 DO - 10.1371/journal.pmed.1000100 ID - Liberati2009 ER - TY - JOUR AU - Miller, A. B. AU - Hoogstraten, B. AU - Staquet, M. AU - Winkler, A. PY - 1981 DA - 1981// TI - Reporting results of cancer treatment JO - Cancer. VL - 47 UR - https://doi.org/3.0.CO;2-6 DO - 3.0.CO;2-6 ID - Miller1981 ER - TY - STD TI - RTOG: RTOG/EORTC Late Radiaton Morbidity Scoring Scheme. https://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx. Accessed 4 Mar 2019. UR - https://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx ID - ref15 ER - TY - JOUR AU - Mazumdar, M. AU - Smith, A. AU - Schwartz, L. H. PY - 2004 DA - 2004// TI - A statistical simulation study finds discordance between WHO criteria and RECIST guideline JO - J Clin Epidemiol VL - 57 UR - https://doi.org/10.1016/j.jclinepi.2003.07.015 DO - 10.1016/j.jclinepi.2003.07.015 ID - Mazumdar2004 ER - TY - STD TI - Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. http://handbook.cochrane.org/. Accessed 4 Mar 2019. UR - http://handbook.cochrane.org/ ID - ref17 ER - TY - JOUR AU - Kishimoto, S. AU - Fujimura, J. AU - Machino, H. AU - Shimamoto, T. AU - Kobayashi, H. AU - Shimizu, S. PY - 1992 DA - 1992// TI - Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats JO - Res Commun Chem Pathol Pharmacol VL - 78 ID - Kishimoto1992 ER - TY - JOUR AU - Yamasaki, K. AU - Sakurai, K. PY - 1994 DA - 1994// TI - Role of lipid peroxidation in protection of rats by rebamipide against gastric mucosal lesions induced by stress plus indomethacin JO - Pathophysiology. VL - 1 UR - https://doi.org/10.1016/0928-4680(94)90006-X DO - 10.1016/0928-4680(94)90006-X ID - Yamasaki1994 ER - TY - JOUR AU - Ishihara, K. AU - Komuro, Y. AU - Nishiyama, N. AU - Yamasaki, K. AU - Hotta, K. PY - 1992 DA - 1992// TI - Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa JO - Arzneimittelforschung. VL - 42 ID - Ishihara1992 ER - TY - JOUR AU - Ogino, K. AU - Hobara, T. AU - Ishiyama, H. AU - Yamasaki, K. AU - Kobayashi, H. AU - Izumi, Y. AU - Oka, S. PY - 1992 DA - 1992// TI - Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats JO - Eur J Pharmacol VL - 212 UR - https://doi.org/10.1016/0014-2999(92)90065-C DO - 10.1016/0014-2999(92)90065-C ID - Ogino1992 ER - TY - JOUR AU - Yoshikawa, T. AU - Naito, Y. AU - Nakamura, S. AU - Nishimura, S. AU - Kaneko, T. AU - Iinuma, S. PY - 1993 DA - 1993// TI - Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats JO - Arzneimittelforschung. VL - 43 ID - Yoshikawa1993 ER - TY - JOUR AU - Naito, Y. AU - Yoshikawa, T. AU - Tanigawa, T. AU - Sakurai, K. AU - Yamasaki, K. AU - Uchida, M. PY - 1995 DA - 1995// TI - Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study JO - Free Radic Biol Med VL - 18 UR - https://doi.org/10.1016/0891-5849(94)00110-6 DO - 10.1016/0891-5849(94)00110-6 ID - Naito1995 ER - TY - JOUR AU - Suzuki, M. AU - Miura, S. AU - Mori, M. AU - Kai, A. AU - Suzuki, H. AU - Fukumura, D. PY - 1994 DA - 1994// TI - Rebamipide, a novel antiulcer agent, attenuates helicobacter pyloni induced gastric mucosal cell injury associated with neutrophil derived oxidants JO - Gut. VL - 35 UR - https://doi.org/10.1136/gut.35.10.1375 DO - 10.1136/gut.35.10.1375 ID - Suzuki1994 ER - TY - JOUR AU - Pignon, J. P. AU - Bourhis, J. AU - Domenge, C. AU - Designé, L. PY - 2000 DA - 2000// TI - Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)90011-4 DO - 10.1016/S0140-6736(00)90011-4 ID - Pignon2000 ER - TY - JOUR AU - Wendt, T. G. AU - Grabenbauer, G. G. AU - Rödel, C. M. AU - Thiel, H. J. AU - Aydin, H. AU - Rohloff, R. PY - 1998 DA - 1998// TI - Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.4.1318 DO - 10.1200/JCO.1998.16.4.1318 ID - Wendt1998 ER - TY - JOUR AU - Kim, C. D. AU - Hong, K. W. PY - 1995 DA - 1995// TI - Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat JO - J Pharmacol Exp Ther VL - 275 ID - Kim1995 ER - TY - JOUR AU - Masamune, A. AU - Yoshida, M. AU - Sakai, Y. AU - Shimosegawa, T. PY - 2001 DA - 2001// TI - Rebamipide inhibits ceramide-induced Interleukin-8 production in Kato III human gastric Cancer cells JO - J Pharmacol Exp Thr VL - 298 ID - Masamune2001 ER - TY - JOUR AU - Baharvand, M. AU - Hamian, M. AU - Moosavizadeh, M. A. AU - Mortazavi, A. AU - Ameri, A. PY - 2015 DA - 2015// TI - Phenytoin mouthwash to treat cancer therapy-induced oral mucositis: a pilot studyPrimaryneuroendocrine carcinoma of breast: a rare tumor JO - Indian J Cancer VL - 52 UR - https://doi.org/10.4103/0019-509X.175597 DO - 10.4103/0019-509X.175597 ID - Baharvand2015 ER -